[{"indications": "Indications\u00a0\n(From 9.6.4 Vitamin D: British National Formulary)\n9.6.4 Vitamin D", "name": "ERGOCALCIFEROL Pharmacological strengths", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.6 Vitamins", "9.6.4 Vitamin D", "ERGOCALCIFEROL", "Pharmacological strengths"], "cautions": "Cautions\u00a0take care to ensure correct dose in infants; monitor plasma-calcium concentration in patients receiving\r\nhigh doses and in renal impairment (\n(From 9.6.4 Vitamin D: British National Formulary)\nImportant. All patients receiving pharmacological doses of vitamin D should have their plasma-calcium concentration checked at intervals (initially once or twice weekly) and whenever nausea or vomiting occur.); interactions: Appendix 1 (vitamins)", "side-effects": "Side-effects\u00a0symptoms of overdosage include\r\nanorexia, lassitude, nausea and vomiting, diarrhoea, constipation,\r\nweight loss, polyuria, sweating, headache, thirst, vertigo, and raised\r\nconcentrations of calcium and phosphate in plasma and urine", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5136.htm", "doses": ["See notes above", "Name[Ergocalciferol (Non-proprietary)] Tablets, ergocalciferol 250\u00a0micrograms\r\n(10\u00a0000\u00a0units), net price 100 = \u00a321.99; 1.25\u00a0mg (50\u00a0000\u00a0units), 100\r\n= \u00a330.34Note\u00a0May be difficult to obtainImportant\u00a0When the strength of the tablets ordered\r\nor prescribed is not clear, the intention of the prescriber with respect\r\nto the strength (expressed in micrograms or milligrams per tablet)\r\nshould be ascertained.\nInjection , for intramuscular use\r\nonly, ergocalciferol, 7.5\u00a0mg (300\u00a0000\u00a0units)/mL in oil, net price\r\n1-mL amp = \u00a39.35, 2-mL amp = \u00a310.84Note\u00a0Other formulations of ergocalciferol are\r\navailable from \u2018special-order\u2019 manufacturers\r\nor specialist importing companies"], "pregnancy": "Pregnancy\u00a0high doses teratogenic in animals but therapeutic doses unlikely to be harmful"}, {"indications": "Indications\u00a0\n(From 9.6.4 Vitamin D: British National Formulary)\n9.6.4 Vitamin D", "name": "ERGOCALCIFEROL", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.6 Vitamins", "9.6.4 Vitamin D", "ERGOCALCIFEROL"], "cautions": "Cautions\u00a0take care to ensure correct dose in infants; monitor plasma-calcium concentration in patients receiving\r\nhigh doses and in renal impairment (\n(From 9.6.4 Vitamin D: British National Formulary)\nImportant. All patients receiving pharmacological doses of vitamin D should have their plasma-calcium concentration checked at intervals (initially once or twice weekly) and whenever nausea or vomiting occur.); interactions: Appendix 1 (vitamins)", "side-effects": "Side-effects\u00a0symptoms of overdosage include\r\nanorexia, lassitude, nausea and vomiting, diarrhoea, constipation,\r\nweight loss, polyuria, sweating, headache, thirst, vertigo, and raised\r\nconcentrations of calcium and phosphate in plasma and urine", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5135.htm", "doses": ["See notes above"], "pregnancy": "Pregnancy\u00a0high doses teratogenic in animals but therapeutic doses unlikely to be harmful"}, {"indications": "Indications\u00a0\n(From 9.6.4 Vitamin D: British National Formulary)\n9.6.4 Vitamin D", "name": "ERGOCALCIFEROL Daily supplements", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.6 Vitamins", "9.6.4 Vitamin D", "ERGOCALCIFEROL", "Daily supplements"], "cautions": "Cautions\u00a0take care to ensure correct dose in infants; monitor plasma-calcium concentration in patients receiving\r\nhigh doses and in renal impairment (\n(From 9.6.4 Vitamin D: British National Formulary)\nImportant. All patients receiving pharmacological doses of vitamin D should have their plasma-calcium concentration checked at intervals (initially once or twice weekly) and whenever nausea or vomiting occur.); interactions: Appendix 1 (vitamins)", "side-effects": "Side-effects\u00a0symptoms of overdosage include\r\nanorexia, lassitude, nausea and vomiting, diarrhoea, constipation,\r\nweight loss, polyuria, sweating, headache, thirst, vertigo, and raised\r\nconcentrations of calcium and phosphate in plasma and urine", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5133.htm", "doses": ["See notes above", "Name[Calcium and Ergocalciferol (Non-proprietary)] Tablets, calcium lactate 300\u00a0mg,\r\ncalcium phosphate 150\u00a0mg (calcium 97\u00a0mg or Ca2+ 2.4\u00a0mmol), ergocalciferol 10\u00a0micrograms (400\u00a0units). Net price 28-tab\r\npack = \u00a37.72. Counselling, crush before administration or may be chewed"], "pregnancy": "Pregnancy\u00a0high doses teratogenic in animals but therapeutic doses unlikely to be harmful"}]